These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 798201)

  • 1. CI-719 in hyperlipoproteinaemia: interim data.
    Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
    Honorato J; Masso RM; Purroy A
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
    [No Abstract]   [Full Text] [Related]  

  • 3. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract]   [Full Text] [Related]  

  • 4. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H; Irsigler K
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrinsic factors affecting the response to gemfibrozil.
    Huunan-Seppälä A; Manninen V; Burton R; Eisalo A
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary of present data from a clinical trial of CI-719.
    Wilkening J; Schwandt P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
    [No Abstract]   [Full Text] [Related]  

  • 9. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
    Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of lipoprotein changes during gemfibrozil treatment.
    Janus ED; Costa D; Ononogbu IC; Lewis B
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
    Rodney G; Uhlendorf P; Maxwell RE
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
    [No Abstract]   [Full Text] [Related]  

  • 13. Gemfibrozil in a group of diabetics.
    de Salcedo I; Gorringe AL; Silva JL; Santos JA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypolipidaemic action of gemfibrozil in adult nephrotics.
    Eisalo A; Manninen V; Mälkönen M; Kuhlbäck B
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):47-8. PubMed ID: 798197
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
    Rasi VP; Torstila I
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):109-11. PubMed ID: 1019149
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phospholipid fractions and free fatty acids in the serum of patients with hypertriglyceridemia treated with 1,5-dicaffeequinine acid].
    Wesołowska T; Szmatłoch E; Wira D; Pieczul-Mróz J; Gregorczyk J
    Przegl Lek; 1986; 43(7):527-30. PubMed ID: 3775065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.